Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies
Clinical trial NCT02030067 · COMPLETED
Trial details
- NCT number
- NCT02030067
- Sponsor
- Processa Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2019-07-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.